Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase III |
| Species: | Human |
| Stage: | Follow-up (closed to accrual) |
| Study Start Date: | 2016-10-21 |
| Study Made Public: | NA |
Title
A pivotal Phase 2b/3 multi-site, randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of ALVAC-HIV (vCP2438) and Bivalent Subtype C gp120/MF59 in preventing HIV-1 infection in adults in South Africa
Description
HVTN 702 is a Phase III clinical trial to evaluate the safety and immunogenicity of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.